Allergies Your Amerigroup Community Care Patients May Experience a Pharmacy Claim Rejection When Prescribed Nonpreferred Products

Allergies Your Amerigroup Community Care Patients May Experience a Pharmacy Claim Rejection When Prescribed Nonpreferred Products

Provider update Hot Tip: Allergies Your Amerigroup Community Care patients may experience a pharmacy claim rejection when prescribed nonpreferred products. To avoid additional steps or delays at the pharmacy, consider prescribing preferred products whenever possible. Utilization Management edits may apply to select preferred products. Coverage should be verified by reviewing the Preferred Drug List (PDL) on the Amerigroup provider website. The PDL is subject to change quarterly. Therapeutic class Preferred products Nonpreferred products Oral • Fexofenadine (generic Allegra) • Cetirizine (generic Zyrtec) antihistamines1 • Fexofenadine/ pseudoephedrine • Cetirizine/pseudoephedrine (generic Allegra-D) (generic Zyrtec D) • Loratadine (generic Claritin) • Zyrtec (cetirizine) • Loratadine/pseudoepherine • Zyrtec D (cetirizine/ (generic Claritin D) pseudoephedrine) • Clarinex (desloratadine) • Desloratadine (generic Clarinex) • Alegra (fexofenadine) • Allegra D (fexofenadine/ pseudoephedrine) • Levocetirizine (generic Xyzal) • Xyzal (levocetirizine) • Claritin (loratadine) • Claritin D (loratadine/ pseudoephedrine) Nasal steroids2 • OTC budesonide nasal spray • Flonase Sensimist (fluticasone (generic Rhinocort) furoate) • OTC Rhinocort Allergy • Flonase (fluticasone propionate) (budesonide) • Rx fluticasone propionate (generic • OTC fluticasone propionate Rx Flonase) (generic Flonase) • Mometasone furoate (generic • OTC triamcinolone acetonide Nasonex) (generic Nasacort) • Nasacort (triamcinolone acetonide) • Nasonex (mometasone furoate) • Omnaris nasal spray (ciclesonide) • Qnasl (beclomethasone dipropionate) • Rx triamcinolone acetonide (generic Rx Nasacort) • Xhance (fluticasone propionate) • Zetonna (ciclesonide) https://providers.amerigroup.com MDPEC-2323-20 August 2020 Therapeutic class Preferred products Nonpreferred products Ophthalmic • Azelastine 0.05% • Alocril 2% (nedocromil sodium) anti-allergy3 • Cromolyn 4% • Alomide 0.1% (lodoxamide • Epinastine 0.05% (generic tromethamine) Elestat) • Bepreve 1.5% (bepotastine • OTC Ketotifen 0.025%4 (generic besilate) Zaditor) • Elestat 0.05% (epinastine) • Emadine 0.05% (emadastine difumarate) • Lastacaft (alcaftadine) • Olopatadine eye drops (generic Patanol & Pataday) • Pataday 0.2% (olopatadine) • Patanol 0.1% (olopatadine) • Pazeo 0.7% (olopatadine) • Zaditor 0.025% (ketotifen) 1 Approval of a nonpreferred non-sedating antihistamine requires trial and failure of both a fexofenadine and loratadine-containing product. 2 Approval of a nonpreferred nasal corticosteroid requires trial and failure of two preferred agents. Some exceptions apply. Please reference the online searchable formulary for full policy details. 3 Approval of a nonpreferred agent requires trial and failure of all preferred ophthalmic anti- allergy agents. Some exceptions apply. Please reference the online searchable formulary for full policy details. 4 Ketotifen is only available as an OTC agent. Examples of product names include Alaway, Allergy Eye, Eye Itch Relief, Itchy Eye. If you have questions regarding this Hot Tip, please call Provider Services at 1-800-454-3730. PDL: https://providers.amerigroup.com/MD Page 2 of 2 .

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    2 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us